Morgan Stanley’s Biophytis SA American Depositary Share (0.01 Euro) BPTS Stock Holding History

Morgan Stanley’s Portfolio BPTS Stock Details BPTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-230	Closed	-$6.17K	–	8024
2023 Q4	$6.17K	Buy	+230	New	+$7.25K	﹤0.01%	6954
2023 Q3	–	Sell	-3	Closed	-$229	–	7727
2023 Q2	$229	Buy	+3	New	+$373	﹤0.01%	7441
2023 Q1	–	Hold	0	–	–	–	7636
2022 Q4	–	Hold	0	–	–	–	7995
2022 Q3	–	Hold	0	–	–	–	7970
2022 Q1	–	Sell	-1	Closed	-$1K	–	8197
2021 Q4	$1K	Hold	1	–	–	﹤0.01%	7904
2021 Q3	$2K	Hold	1	–	–	﹤0.01%	7695
2021 Q2	$2K	Hold	1	–	–	﹤0.01%	7552
2021 Q1	$3K	Buy	+1	New	+$5.99K	﹤0.01%	7230

Other funds holding BPTS

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Morgan Stanley's BPTS Position: Q1 2024 in Review

Morgan Stanley sold out of Biophytis SA American Depositary Share (0.01 Euro) (BPTS) in Q1 2024, closing a stake of 230 shares — an estimated $6.17K sold.

Morgan Stanley first reported a position in BPTS in Q1 2021 and held it in 6 quarters. The position peaked at $6.17K in Q4 2023. 2 funds tracked by Wall St. Rank hold BPTS as of Q1 2024.

Morgan Stanley reported no remaining Biophytis SA American Depositary Share (0.01 Euro) position as of Q1 2024 after selling out during the quarter.
Morgan Stanley sold 230 Biophytis SA American Depositary Share (0.01 Euro) shares in Q1 2024, an estimated $6.17K.
Morgan Stanley first reported a position in Biophytis SA American Depositary Share (0.01 Euro) in Q1 2021 and held it in 6 quarters.
Morgan Stanley's Biophytis SA American Depositary Share (0.01 Euro) position peaked at $6.17K in Q4 2023.
2 funds tracked by Wall St. Rank held Biophytis SA American Depositary Share (0.01 Euro) as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.